Approval · Notice of Compliance 1809 · 2003
GLYSET: Notice of Compliance 1809
Issued October 28, 2003
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 1809
- Date
- October 28, 2003
- Company
- Pfizer Canada UlcKirkland, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Oral antidiabetic agent, alpha-gucosidase inhibitor
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| GLYSET | 02239474 | — |
| GLYSET | 02239475 | — |
| GLYSET | 02239476 | — |